What is a stock summary page? Click here for an overview.
Business Description
Pulse Biosciences Inc
NAICS : 339113
SIC : 3841
ISIN : US74587B1017
Description
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.27 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 24.3 | |||||
| 3-Year EPS without NRI Growth Rate | 25.7 | |||||
| 3-Year FCF Growth Rate | 31.2 | |||||
| 3-Year Book Growth Rate | 13.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 29.97 | |||||
| 9-Day RSI | 33.16 | |||||
| 14-Day RSI | 35.05 | |||||
| 3-1 Month Momentum % | -1.18 | |||||
| 6-1 Month Momentum % | 14.38 | |||||
| 12-1 Month Momentum % | 136.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.88 | |||||
| Quick Ratio | 11.88 | |||||
| Cash Ratio | 11.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.7 | |||||
| Shareholder Yield % | -4.19 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -88.83 | |||||
| ROA % | -71.59 | |||||
| ROIC % | -321.87 | |||||
| 3-Year ROIIC % | -258.3 | |||||
| ROC (Joel Greenblatt) % | -678.01 | |||||
| ROCE % | -82.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 8.65 | |||||
| Price-to-Tangible-Book | 8.95 | |||||
| EV-to-EBIT | -16.07 | |||||
| EV-to-EBITDA | -16.41 | |||||
| EV-to-Forward-Revenue | 7.94 | |||||
| EV-to-FCF | -24.79 | |||||
| Price-to-Net-Current-Asset-Value | 9.79 | |||||
| Price-to-Net-Cash | 9.93 | |||||
| Earnings Yield (Greenblatt) % | -6.22 | |||||
| FCF Yield % | -3.6 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pulse Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.834 | ||
| Beta | 2.93 | ||
| 3-Year Sharpe Ratio | 0.79 | ||
| 3-Year Sortino Ratio | 1.96 | ||
| Volatility % | 80.27 | ||
| 14-Day RSI | 35.05 | ||
| 14-Day ATR (€) | 0.607331 | ||
| 20-Day SMA (€) | 14.85 | ||
| 12-1 Month Momentum % | 136.31 | ||
| 52-Week Range (€) | 6.029275 - 23 | ||
| Shares Outstanding (Mil) | 67.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pulse Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pulse Biosciences Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pulse Biosciences Inc Frequently Asked Questions
What is Pulse Biosciences Inc(STU:6L8)'s stock price today?
The current price of STU:6L8 is €13.70. The 52 week high of STU:6L8 is €23.00 and 52 week low is €6.03.
When is next earnings date of Pulse Biosciences Inc(STU:6L8)?
The next earnings date of Pulse Biosciences Inc(STU:6L8) is 2025-05-07 Est..
Does Pulse Biosciences Inc(STU:6L8) pay dividends? If so, how much?
Pulse Biosciences Inc(STU:6L8) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers